OLIVETO JOSEPH (President and CEO) received a stock award from MILESTONE PHARMACEUTICALS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 7/15/2025ACC: 0001415889-25-019772
DirectorOfficer· President and CEO
Since May 2019
+200K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
200K acquired
Non-Derivative Transactions1
Common Shares
Direct
Shares
+66.67K
Price / share
—
Trade value
—
% of position
23.8%
7/11/2025
280.56K→347.22K
Total
Net shares
+66.67K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 7/11/2025 | A · Award | +66.67K | — | — | 23.8% | 280.56K | 347.22K |
| Total | +66.67K | $0.00 | ||||||
Derivative Transactions2
Series A Common Warrants (right to buy)
Direct
Converts to
Common Shares
66.67K shares
Shares
+66.67K
Strike price
1.50
Held after
66.67K
Exercisable
—
7/11/2025
Series B Common Warrants (right to buy)
Direct
Converts to
Common Shares
66.67K shares
Shares
+66.67K
Strike price
1.875
Held after
66.67K
Exercisable
—
7/11/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series A Common Warrants (right to buy) Direct | Common Shares66.67K shares | 7/11/2025 | A · Award | +66.67K | 1.50 | — | 66.67K |
| Series B Common Warrants (right to buy) Direct | Common Shares66.67K shares | 7/11/2025 | A · Award | +66.67K | 1.875 | — | 66.67K |